Literature DB >> 12745317

Neurotic disorders and the receipt of psychiatric treatment.

P Bebbington1, T Brugha, H Meltzer, R Jenkins, C Ceresa, M Farrell, G Lewis.   

Abstract

Access to psychiatric treatment by people with neurotic disorders in the general population is likely to be affected both by the severity of disorder and by sociodemographic differences. In the household component of the National Surveys of Psychiatric Morbidity >10,000 subjects in Great Britain with psychiatric symptoms were interviewed using the CIS-R. They were also asked about difficulties experienced in performing seven types of everyday activity. All subjects classed as having an ICD-10 disorder were questioned about their experience of treatment with antidepressants, hypnotics, and counselling or psychotherapy. Less than 14% of people with current neurotic disorders were receiving treatment for them. Within the previous year, only a third had made contact with their primary care physician for their mental problem: of these <30% were receiving treatment. Overall, 9% of people with disorders were given medication and 8% counselling or psychotherapy. A diagnosis of depressive episode was that most associated with antidepressant medication. Treatment access was affected by employment status, marital status, and age, but the major determinant was symptom severity. Neither sex nor social class influenced which people received treatment. People with psychiatric disorders seldom receive treatment, even when they have consulted their primary care physician about them. In many cases, this must represent unmet needs with a strong claim on health resources. There are also inequalities in the receipt of treatment, although the major influence is the severity of disorder.

Entities:  

Mesh:

Year:  2003        PMID: 12745317     DOI: 10.1080/0954026021000046010

Source DB:  PubMed          Journal:  Int Rev Psychiatry        ISSN: 0954-0261


  13 in total

Review 1.  Clinical applications of EEG as an excellent tool for event related potentials in psychiatric and neurotic disorders.

Authors:  Charushila Jadhav; Priti Kamble; Shafique Mundewadi; Nitesh Jaiswal; Snehalata Mali; Surbhi Ranga; Tarun Kumar Suvvari; Atul Rukadikar
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2022-04-15

2.  Psychotropic drug use in Israel: results from the national health survey.

Authors:  Alexander Grinshpoon; Eli Marom; Abraham Weizman; Alexander M Ponizovsky
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

3.  Twelve-month treatment of psychiatric disorders in the South African Stress and Health Study (World Mental Health Survey Initiative).

Authors:  Soraya Seedat; D J Stein; A Herman; R Kessler; J Sonnega; S Heeringa; S Williams; D Williams
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-08-02       Impact factor: 4.328

4.  Religious versus Conventional Internet-based Cognitive Behavioral Therapy for Depression.

Authors:  Bogdan Tudor Tulbure; Gerhard Andersson; Nastasia Sălăgean; Michelle Pearce; Harold G Koenig
Journal:  J Relig Health       Date:  2018-10

5.  Potentially inappropriate use of psychotropic medications in hospitalized elderly patients in France: cross-sectional analysis of the prospective, multicentre SAFEs cohort.

Authors:  Max Prudent; Moustapha Dramé; Damien Jolly; Thierry Trenque; Renaud Parjoie; Rachid Mahmoudi; Pierre-Olivier Lang; Dominique Somme; François Boyer; Isabelle Lanièce; Jean-Bernard Gauvain; François Blanchard; Jean-Luc Novella
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

6.  The use of mental health services among young adults with emotional and behavioural problems: equal use for equal needs?

Authors:  Kathleen Vanheusden; Jan van der Ende; Cornelis L Mulder; Frank J van Lenthe; Frank C Verhulst; Johan P Mackenbach
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-05-29       Impact factor: 4.328

7.  Depressive symptoms among adults 18-69 years in Italy: results from the Italian behavioural risk factor surveillance system, 2007.

Authors:  Nancy Binkin; Antonella Gigantesco; Gianluigi Ferrante; Sandro Baldissera
Journal:  Int J Public Health       Date:  2009-12-22       Impact factor: 3.380

8.  Effectiveness of a novel integrative online treatment for depression (Deprexis): randomized controlled trial.

Authors:  Björn Meyer; Thomas Berger; Franz Caspar; Christopher G Beevers; Gerhard Andersson; Mario Weiss
Journal:  J Med Internet Res       Date:  2009-05-11       Impact factor: 5.428

9.  The clinical effectiveness of web-based cognitive behavioral therapy with face-to-face therapist support for depressed primary care patients: randomized controlled trial.

Authors:  Ragnhild Sørensen Høifødt; Kjersti R Lillevoll; Kathleen M Griffiths; Tom Wilsgaard; Martin Eisemann; Knut Waterloo; Nils Kolstrup
Journal:  J Med Internet Res       Date:  2013-08-05       Impact factor: 5.428

10.  Internet-based treatment of major depression for patients on a waiting list for inpatient psychotherapy: protocol for a multi-centre randomised controlled trial.

Authors:  Jo Annika Reins; David Daniel Ebert; Dirk Lehr; Heleen Riper; Pim Cuijpers; Matthias Berking
Journal:  BMC Psychiatry       Date:  2013-11-26       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.